| Literature DB >> 31532913 |
Kazuomi Kario1, Jinho Shin2, Chen-Huan Chen3, Peera Buranakitjaroen4, Yook-Chin Chia5,6, Romeo Divinagracia7, Jennifer Nailes7, Satoshi Hoshide1, Saulat Siddique8, Jorge Sison9, Arieska Ann Soenarta10, Guru Prasad Sogunuru11,12, Jam Chin Tay13, Boon Wee Teo14, Yuda Turana15, Yuqing Zhang16, Sungha Park17, Huynh Van Minh18, Ji-Guang Wang19.
Abstract
Hypertension is an important public health issue because of its association with a number of significant diseases and adverse outcomes. However, there are important ethnic differences in the pathogenesis and cardio-/cerebrovascular consequences of hypertension. Given the large populations and rapidly aging demographic in Asian regions, optimal strategies to diagnose and manage hypertension are of high importance. Ambulatory blood pressure monitoring (ABPM) is an important out-of-office blood pressure (BP) measurement tool that should play a central role in hypertension detection and management. The use of ABPM is particularly important in Asia due to the specific features of hypertension in Asian patients, including a high prevalence of masked hypertension, disrupted BP variability with marked morning BP surge, and nocturnal hypertension. This HOPE Asia Network document summarizes region-specific literature on the relationship between ABPM parameters and cardiovascular risk and target organ damage, providing a rationale for consensus-based recommendations on the use of ABPM in Asia. The aim of these recommendations is to guide and improve clinical practice to facilitate optimal BP monitoring with the goal of optimizing patient management and expediting the efficient allocation of treatment and health care resources. This should contribute to the HOPE Asia Network mission of improving the management of hypertension and organ protection toward achieving "zero" cardiovascular events in Asia. ©2019 Wiley Periodicals, Inc.Entities:
Keywords: Asia; ambulatory blood pressure monitoring; blood pressure variability; cardiovascular risk; hypertension; nocturnal hypertension
Mesh:
Substances:
Year: 2019 PMID: 31532913 PMCID: PMC8030405 DOI: 10.1111/jch.13652
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738